VAERS reports by lot

Sanofi Pasteur DTaP/Tdap lot U7624AA: VAERS reports

21 VAERS reports list lot U7624AA as a Sanofi Pasteur DTaP/Tdap vaccine, received between 2022-10-05 and 2024-12-13. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
21
Reports
0%
Marked serious
0
With a death outcome
10
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction1324%
Cardiac / Cardiovascular916%
Gastrointestinal713%
Neurological611%
Allergic / Anaphylactic47%
Dermatological (non-injection-site)47%
General / Systemic (non-local)47%
Autoimmune / Immune-mediated35%
Respiratory35%
Thrombotic / Hematological12%
Musculoskeletal12%

Where reports came from

U.S. state of the reporter, where given (top 12).

California4
Texas3
Minnesota2
Rhode Island2
Oregon2
Virginia1
New York1
Arizona1
Georgia1
Indiana1
New Jersey1
Tennessee1

Reports by month received

2022-103
2022-111
2022-122
2023-013
2023-035
2023-071
2023-082
2023-092
2023-101
2024-121

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.